Release Date: 26/06/09 09:33 Summary: Results of Special Shareholder Meeting Price Sensitive: No Download Document 60.15KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%